SHORT ANSWER
Next to the claim it qualifies, on the same page, visible without scrolling or clicking, and repeated at cart and checkout. The FTC treats footer-only, hyperlink-only, and one-time popup disclosures as avoidable, and no placement helps when the disclaimer sits beside copy that contradicts it. Placement is a recommended control, not a fix for the surrounding claims.
This material is general educational information as of the “last reviewed” date. It is not legal advice and may not reflect later developments or facts specific to your business. Links are provided so readers can inspect the primary or official sources.
01 / WHAT A DISCLOSURE CAN DO
It can qualify an ambiguous claim. It cannot reverse a clear one.
The FTC's Health Products Compliance Guidance draws the line in one sentence: a clear and conspicuous disclosure “can’t directly contradict a claim.” It can clarify something that would otherwise mislead by omission. It cannot take back a product page that describes fat loss, glucose control, or muscle repair in people.
That is the boundary this guide works inside. The question of whether a research-use-only line changes intended use at all is answered in the guides linked below; FDA's peptide letters set the line aside in 15 of the 185 letters RUO Clear compiled, and never treated it as controlling. This guide is about the narrower job a disclaimer can still do: telling a reader accurately what the product is and is not sold for, in a place where they will actually see it.
Nothing below is a rule from a regulator about where a peptide disclaimer must sit. It is RUO Clear's reading of the FTC's disclosure factors applied to a storefront. Whether any placement is adequate depends on the surrounding claims.
02 / THE FTC FACTORS
Clear and conspicuous, applied to a web page
The FTC judges a disclosure by whether consumers notice and understand it, and the guidance names the things that decide that. On a storefront each factor has a concrete meaning.
- Proximity: the disclosure sits close to the claim it qualifies. The guidance says an effective disclosure “may actually need to be incorporated into the claim.” A product-page claim qualified by a footer three screens down is not proximate.
- Prominence: the disclosure is as legible as the claim. The guidance faults a disclaimer whose “placement and size” are too small to qualify the statement it follows.
- Unavoidability: on the internet and in interactive media the disclosure “should be unavoidable; disclosures made through hyperlinks are avoidable.” A “Terms” link and a collapsed accordion are hyperlinks.
- Consistency: a disclosure “should not be contradicted or mitigated by, or inconsistent with, anything else” in the presentation. This is the factor a peptide storefront most often fails.
- Mobile: the same test applies to the screen the buyer is actually on. A disclosure that is visible on desktop and pushed below the fold on a phone is avoidable on the phone.
03 / RECOMMENDED PLACEMENTS
Where the boundary language belongs, surface by surface
The pattern is repetition at each point where a claim is made or a decision is taken. One statement in one place is what the FTC calls avoidable; the same statement met four times on the way to an order is not.
- Product page: directly under the product name or beside the description, before the add-to-cart control, in body-size text. This is the placement that matters most, because the product page is where FDA quoted claims in 19 of the compiled letters.
- Collection and category pages: a short line at the top of the list, so a reader who never opens a product page still meets it.
- Cart and checkout: repeated where the buyer confirms the order, as text on the page rather than inside a checkbox label alone.
- Policy page: a full-length version, linked from the short lines above, that states what the products are sold for and what the seller does not represent.
- Order confirmation and packaging insert: the same boundary language on the confirmation page, the email, and any insert, so the record after the sale matches the record before it.
- Site-wide footer: keep it, but as the last placement rather than the only one.
04 / WHERE IT DOES NOT HELP
Placements that read as avoidable, or as contradicted
Most storefronts that have a disclaimer have it in one of these places. Each fails one of the factors above.
- Footer only: not proximate to any claim, usually not prominent, and on a phone often never reached.
- Terms page only: a hyperlink, which the guidance treats as avoidable on its face.
- One-time popup or age gate: seen once, dismissed, and absent from every page where a claim is actually made.
- Collapsed accordion or tooltip: hidden behind an interaction, which is the hover-only problem in another form.
- Beside a contradicting claim: a “not for human consumption” line under a description of appetite suppression in people is the exact pattern FDA quoted in the February 2025 USApeptide letter, which listed four separate boundary statements from the site before setting all of them aside.
- Inside a checkout checkbox alone: an attestation records what the buyer clicked; it does not qualify the claims on the product page. The checkout guide linked below covers why.
A disclaimer can be proximate, prominent, and unavoidable and still do nothing, because the claim next to it says the opposite. Fix the claim first; place the disclaimer second.
05 / WORDING DISCIPLINE
The disclaimer has to be true on its own
A boundary statement is itself a representation. If the storefront sells reconstitution supplies, publishes dosing schedules, or hosts reviews describing personal results, a line that says the products are “not for human consumption” is contradicted by the seller's own content, and the FTC's consistency factor treats that as a defect in the disclosure, not a cure.
Keep the language plain and accurate: what the product is sold for, who the intended buyer is, and what the seller does not claim. Avoid adding assurances the seller cannot support, such as statements about legality, safety, or purity, since those are new claims subject to the same substantiation rules as everything else on the page.
- State the intended use in the affirmative rather than only in the negative.
- Do not pair the boundary line with outcome language, brand comparisons, or dosing anywhere on the same page.
- Do not describe the disclaimer as making the sale lawful, compliant, or approved; that is a legal conclusion the seller is not in a position to make in ad copy.
- Keep one canonical wording and reuse it verbatim across surfaces, so the record is consistent.
06 / REVIEW CHECKLIST
How to check placement on your own storefront
Walk the buyer's path on a phone, not a desktop, and record where the boundary language appears and what sits next to it.
- Is the disclaimer on every product page, near the name and description, above the add-to-cart control?
- Is it visible without scrolling, clicking, hovering, or expanding anything?
- Is it repeated at the collection page, the cart, and the checkout confirmation?
- Is it in the order confirmation and any packaging insert?
- On each page where it appears, does any other text, image, review, or bundle contradict it?
- Is the wording identical everywhere, and is every statement in it true of the storefront as it actually exists?
QUESTIONS
Related questions
Is a footer disclaimer better than nothing?
It is not harmful, but the FTC's factors treat a footer-only disclosure as avoidable and not proximate to the claims it is meant to qualify. Keep it as the last placement, not the only one.
Does a checkout checkbox count as a disclosure?
It records what the buyer accepted. It does not qualify the claims on the product page, which is where FDA quoted language in most of the letters RUO Clear compiled. Place the boundary text on the page as well.
If I place the disclaimer correctly everywhere, is my site compliant?
Placement does not decide that. A disclosure cannot contradict a claim, and FDA reads intended use from the whole presentation. Placement is a recommended control for accuracy and visibility; the claims around it are what a reviewer reads.
SOURCES
Sources cited
Each source is listed with its class so government authority, agency guidance, enforcement examples, and private policy are never blended into one rule.
Clear and conspicuous disclosure: proximity, prominence, unavoidability, and the rule that a disclosure cannot contradict a claim.
Staff guidance on placement, proximity, scrolling, hyperlinks, and repetition for disclosures on websites and mobile screens.
Why placement cannot substitute for the surrounding presentation: intent is read from labeling, advertising, and circumstances of distribution.
Quotes four separate boundary statements from the site before setting them aside because of the claims beside them.